Changes in prostate-specific antigen at the time of prostate cancer diagnosis after Medicaid expansion in young men.

In Medicaid expansion states, there was an associated decrease in the proportion of young men presenting with PSA ≥20 ng/mL at the time of PCa diagnosis. These results suggest that Medicaid expansion improved access to PCa screening. Longer term data should assess oncologic outcomes.